Free Trial

Sensei Biotherapeutics (SNSE) Institutional Ownership

Sensei Biotherapeutics logo
$20.32 -0.76 (-3.62%)
As of 02:24 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Sensei Biotherapeutics (NASDAQ:SNSE)

Current
Institutional Ownership
Percentage
10.50%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$11.74K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$12.23K
Get SNSE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SNSE Institutional Buying and Selling by Quarter

Sensei Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC21,351$228K0.0%-5.1%1.695%
2/12/2026Renaissance Technologies LLC11,516$123K0.0%+10.6%0.913%
2/13/2025XTX Topco Ltd62,903$31K0.0%+351.7%0.250%
2/13/2025Renaissance Technologies LLC156,800$77K0.0%-27.3%0.623%
11/15/2024National Bank of Canada FI45,575$27K0.0%+355.8%0.181%
11/14/2023Newtyn Management LLC1,800,000$1.35M0.3%-1.5%7.200%
11/14/2022RA Capital Management L.P.683,529$1.06M0.0%-5.5%2.225%
7/22/2022Truist Financial Corp19,934$45K0.0%-60.5%0.065%
5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048%


SNSE Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Sensei Biotherapeutics shares: Ikarian Capital LLC ($228K), Renaissance Technologies LLC ($123K), and XTX Topco Ltd ($31K), National Bank of Canada FI ($27K).Learn more on Sensei Biotherapeutics' institutional investors.

10.50% of Sensei Biotherapeutics' stock is owned by institutional investors. Learn more on SNSE's institutional investor holdings.

The following institutional investors have purchased Sensei Biotherapeutics' stock in the last 24 months: XTX Topco Ltd ($48.98K), National Bank of Canada FI ($35.58K), and Renaissance Technologies LLC ($1.10K).

Institutional investors have bought a total of 1,100 shares in the last 24 months. This purchase volume represents approximately $11.74K in transactions.

The following institutional investors have sold Sensei Biotherapeutics stock in the last 24 months: Ikarian Capital LLC ($1.15K).

Institutional investors have sold a total of 1,146 shares in the last 24 months. This volume of shares sold represents approximately $12.23K in transactions.



This page (NASDAQ:SNSE) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners